BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38072324)

  • 1. Trends in Utilization and Medicare Spending on Short-Course Radiation Therapy for Breast and Prostate Cancer: An Episode-Based Analysis From 2015 to 2019.
    Patel TA; Jain B; Vapiwala N; Chino F; Tringale KR; Mahal BA; Yamoah K; McBride SN; Lam MB; Hubbard A; Nguyen PL; Dee EC
    Int J Radiat Oncol Biol Phys; 2024 May; 119(1):17-22. PubMed ID: 38072324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Use of Hypofractionated Radiotherapy for Primary CNS Tumors in the Elderly, and Implications on Medicare Spending.
    Tringale KR; Lin A; Miller AM; Khan A; Chen L; Zinovoy M; Yamada Y; Yu Y; Pike LRG; Imber BS
    J Natl Compr Canc Netw; 2024 Apr; ():1-7. PubMed ID: 38688308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer Database.
    Mak KS; Agarwal A; Qureshi MM; Truong MT
    Cancer Med; 2017 Jun; 6(6):1192-1200. PubMed ID: 28440040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and Quality.
    Dee EC; Taunk NK; Chino FL; Deville C; McClelland S; Muralidhar V; McBride SN; Gillespie EF; Yamoah K; Nguyen PL; Mahal BA; Winkfield KM; Vapiwala N; Santos PMG
    JCO Oncol Pract; 2023 Feb; 19(2):e197-e212. PubMed ID: 36399692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer.
    Yu JB; Sun Y; Jia AY; Vince RA; Shoag JE; Zaorsky NG; Spratt DE
    JAMA Oncol; 2023 Dec; 9(12):1696-1701. PubMed ID: 37796479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of total neoadjuvant therapy with 5 × 5 Gy radiation therapy versus conventional chemoradiotherapy for locally advanced rectal cancer among Peruvians.
    Díaz JFR; Changra HO
    Ecancermedicalscience; 2022; 16():1406. PubMed ID: 36072238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-Type-I Response and Systemic Immunity in Rectal Adenocarcinoma Patients Treated with Conventional or Hypofractionated Neoadjuvant Radiotherapy.
    Koukourakis IM; Xanthopoulou E; Koukourakis MI; Tiniakos D; Kouloulias V; Zygogianni A
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-Term Outcomes and Cost-Effectiveness between Long-Course Chemoradiation and Short-Course Radiotherapy for Locally Advanced Rectal Cancer.
    Cho MS; Bae HW; Chang JS; Yang SY; Kim TH; Koom WS; Shin SJ; Choi GS; Kim NK
    Yonsei Med J; 2023 Jun; 64(6):395-403. PubMed ID: 37226566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis.
    Zhou ZR; Liu SX; Zhang TS; Chen LX; Xia J; Hu ZD; Li B
    Surg Oncol; 2014 Dec; 23(4):211-21. PubMed ID: 25466851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes.
    Baumgardner J; Shahabi A; Linthicum M; Vine S; Zacker C; Lakdawalla D
    J Manag Care Spec Pharm; 2018 Jun; 24(6):504-513. PubMed ID: 29799330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of neoadjuvant short-course radiation therapy followed by transanal endoscopic microsurgery for t1-t2 n0 extraperitoneal rectal cancer.
    Arezzo A; Arolfo S; Allaix ME; Munoz F; Cassoni P; Monagheddu C; Ricardi U; Ciccone G; Morino M
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):299-306. PubMed ID: 25772184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant short-course radiotherapy with consolidation chemotherapy for locally advanced rectal cancer: a systematic review and meta-analysis.
    Patel A; Spychalski P; Corrao G; Jereczek-Fossa BA; Glynne-Jones R; Garcia-Aguilar J; Kobiela J
    Acta Oncol; 2021 Oct; 60(10):1308-1316. PubMed ID: 34308767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials.
    Tabrizi S; Trippa L; Cagney D; Aizer AA; Tanguturi S; Ventz S; Fell G; Bellon JR; Mamon H; Nguyen PL; D'Amico AV; Haas-Kogan D; Alexander BM; Rahman R
    JAMA Netw Open; 2021 Mar; 4(3):e213304. PubMed ID: 33779742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care Model.
    Baumgardner JR; Shahabi A; Linthicum MT; Zacker C; Lakdawalla DN
    J Oncol Pract; 2018 Nov; 14(11):e699-e710. PubMed ID: 30423271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival in rectal cancer patients who are treated with long-course versus short-course neoadjuvant radiotherapy: A propensity-matched analysis of the NCDB.
    Chapman BC; Goodman K; Hosokawa P; Gleisner A; Cowan ML; Birnbaum E; Vogel JD
    J Surg Oncol; 2019 Mar; 119(4):518-531. PubMed ID: 30637750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose escalation of preoperative short-course radiotherapy followed by neoadjuvant chemotherapy in locally advanced rectal cancer: protocol for an open-label, single-centre, phase I clinical trial.
    Zhang MX; Li XB; Guan BJ; Guan GX; Lin XY; Wu XD; Chi P; Xu BH
    BMJ Open; 2019 Mar; 9(3):e025944. PubMed ID: 30904869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation Therapy Expenditures Through the First 8 Performance Periods of the Oncology Care Model at a Statewide Multispecialty Health System.
    De B; Andres G; Bates C; Staren E; Kutscher E; Brooks DJ; Thaker GH; Buscema J; Gin R; Thaker N
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):491-499. PubMed ID: 36427644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care resource utilization, quality metrics, and costs of bladder cancer within the Oncology Care Model.
    Wirtz HS; Hepp Z; Grewal S; Wright P; Fuldeore R; Tomicki S; Hirsch J; Dieguez G; Blakely LJ
    Am J Manag Care; 2023 May; 29(5):e136-e142. PubMed ID: 37229787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-course Versus Long-course Preoperative Radiotherapy plus Delayed Surgery in the Treatment of Rectal Cancer: a Meta-analysis.
    Liu SX; Zhou ZR; Chen LX; Yang YJ; Hu ZD; Zhang TS
    Asian Pac J Cancer Prev; 2015; 16(14):5755-62. PubMed ID: 26320447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between a Bundled Payment Program for Lower Extremity Joint Replacement and Patient Outcomes Among Medicare Advantage Beneficiaries.
    Sutherland A; Boudreau E; Bowe A; Huang Q; Liao JM; Flagg M; Cousins D; Antol DD; Shrank WH; Powers BW; Navathe AS
    JAMA Health Forum; 2023 Jun; 4(6):e231495. PubMed ID: 37355996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.